As a peptide-based prescription drug, semaglutide requires specific storage conditions to maintain its structural integrity and therapeutic efficacy
This proposition is based on the stable expression levels of MyoD and myogenin, which are considered to be pivotal markers of satellite cell proliferation and differentiation, respectively
In addition, a selective GIP agonist showed very low effectiveness in reducing weight, while this co-agonist showed synergism in reducing fat mass in obese rodents
Recent clinical observations suggest that rapid weight loss itself, rather than semaglutide directly, may trigger temporary hair loss in some patients
High levels of ammonia lead to fatigue, weakness, confusion, and in severe cases, coma or death